Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol total intravenous anesthesia for postoperative nausea and vomiting in thyroid surgery
ChiCTR2500100324Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and propofol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of postoperative nausea and vomiting. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500100324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100324.